Back to articles

SJCH's Quest Imaging Offers Tool for Early Detection of Alzheimer's Disease

News A new tool in the field of radiology is providing families dealing with Alzheimer’s more accurate information and sooner.

Quest Imaging at San Joaquin Community Hospital (SJCH) is proud to offer NeuroQuant®, the most precise tool available for giving early diagnosis for Alzheimer’s disease and other neurodegenerative disorders.

“This is really a breakthrough technology – it’s a software that measures regional brain structures that typically deteriorate in patients with Alzheimer’s disease and compares the results to peers with healthy brains using the only FDA-approved database,” said Dr. Lorraine Ash, D.O., of Quest Imaging. “This can give people that extra time to make the best decisions for their loved ones.”

Alzheimer’s disease is the sixth leading cause of death in the United States and affects 5.4 million Americans and almost 10,000 in Kern County alone. Thirty million baby boomers will be affected by Alzheimer’s disease. When it comes to memory loss, how do you know what’s normal? NeuroQuant® is able to answer that question and more.

NeuroQuant® can also assist doctors in making a diagnosis and following the progression of Alzheimer’s disease in a convenient and cost-effective way. Additionally, NeuroQuant® results can monitor the speed at which the disease is progressing, changes in the atrophy of the brain and has the potential to impact the early identification of patients needing aggressive treatment.

To learn more about NeuroQuant®, available now at Quest Imaging, or if this story is something that fits with your health news coverage, feel free to contact that SJCH marketing department. We are happy to set up interviews at your convenience. Please call us directly at (661) 869-6560.